To further define the effectors responsible for the anti-tumor cell immunity, CD4+ or CD8+ T-lymphocytes were depleted from Balb/c mice by injection of either anti-CD4 or anti-CD8 specific antibodies. The gene discussed is CD4; the disease is neoplasm.